Vanqua Bio’s $85 Million Series B Financing

Fenwick & West advised Vanqua Bio on the deal.Vanqua Bio, a biopharmaceutical company dedicated to discovering and developing next-generation medicines for neurodegenerative diseases, announced its $85 million…

Membership Required

You must be a member to access this content.

View Membership Levels

Already a member? Log in here
  Share:
Martina Bellini

Author: Martina Bellini

…

Membership Required

You must be a member to access this content.

View Membership Levels

Already a member? Log in here